Diabetes Drug Can Cut Risk of Kidney Stones
Discover the potential of SGLT2 inhibitors- a class of diabetes drugs, in mitigating kidney stones risk in diabetic patients.
Source: medindia.net
Nephrolithiasis Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nephrolithiasis Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nephrolithiasis Risk Today - Breaking & Trending Today
Diabetes medication class tied to lower risk
<p>Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones. In a study led by investigators from <a href="https://www.massgeneralbrigham.org/" target="_blank">Mass General Brigham</a>, researchers found that there was an association between the use of sodium-glucose contratransporter 2 (SGLT2) inhibitors and a lower risk of developing kidney stones. Their findings are reported in <a href="https://jamanetwork.com/journals/jamaintern...
Source: eurekalert.org
SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes
Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.
Source: hcplive.com